In order to report adverse drug reactions (ADRs) for drugs used in prophylaxis for treatment of COVID-19, the Indian Pharmacopoeia Commission (IPC) has rolled out a suspected ADR reporting form for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback